Get started
Author

Chel Hun Choi

Observed names: C Choi, C H Choi, C-H. Choi, C. Choi, C.H. CHOI, C.H. Choi, CHEL HUN CHOI, Chel Choi, Chel H Choi, Chel Hun CHOI, Chel-Hun Choi, Choi Chel‐Hun, Choi, C.H., Choi, Chel
Observed institutions: National Institutes of Health, Seoul National University, Gunma University, Yonsei University, Severance Hospital, Samsung Medical Center, Seoul National University Hospital, Kangbuk Samsung Hospital, Inje University Busan Paik Hospital, National Cancer Institute, Gangnam Severance Hospital, Kantonsspital Graubünden, Center for Cancer Research, Yonsei University Health System, Cheil General Hospital and Women's Healthcare Center, Gunma University Hospital, Leidos Biomedical Research Inc. (United States), Yonsei Cancer Hospital, Kyungpook National University Chilgok Hospital, Samsung Seoul Hospital, Korea University Guro Hospital, Chung-Ang University Gwangmyeong Hospital, Korea University Ansan Hospital, Sungkyunkwan University
ORCID: 0000-0002-0199-6669
Observed ORCID: 0000-0002-0199-6669
OpenAlex ID: A5061006522
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
2017 · Eric Pujade-Lauraine, Jonathan A Ledermann, et al. · The Lancet Oncology · 1,856
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
2021 · Andrés Poveda, Anne Floquet, et al. · The Lancet Oncology · 425
Altered MicroRNA Expression in Cervical Carcinomas
2008 · Jeong-Won Lee, Chel Hun Choi, et al. · Clinical Cancer Research · 309
Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study
2011 · In Ho Lee, Chel Hun Choi, et al. · Journal of Gynecologic Oncology · 155
PDF
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
2012 · Yoo-Young Lee, Chel Hun Choi, et al. · PubMed · 146
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
2024 · Nicoletta Colombo, Elena Biagioli, et al. · The Lancet Oncology · 138
Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes
2010 · Tae-Joong Kim, Yoo-Young Lee, et al. · Surgical Endoscopy · 137
Single-Port Access Laparoscopic-Assisted Vaginal Hysterectomy: A Novel Method with a Wound Retractor and a Glove
2009 · Yoo-Young Lee, Tae-Joong Kim, et al. · Journal of Minimally Invasive Gynecology · 137
Single Port Access Laparoscopic Adnexal Surgery
2009 · Tae-Joong Kim, Yoo-Young Lee, et al. · Journal of Minimally Invasive Gynecology · 129
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis
2011 · Yoo-Young Lee, Tae-Joong Kim, et al. · Gynecologic Oncology · 122
Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes
2010 · Yoo-Young Lee, Tae-Joong Kim, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 105
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
2011 · Yoo-Young Lee, Chel Hun Choi, et al. · Gynecologic Oncology · 102
Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
2015 · Bo Wook Kim, Hanbyoul Cho, et al. · BMC Cancer · 101
PDF
A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB–IIA
2010 · Yoo-Young Lee, Chel Hun Choi, et al. · Gynecologic Oncology · 100
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
2011 · Yoo-Young Lee, Chel Hun Choi, et al. · Gynecologic Oncology · 98
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells
2017 · Kwon-Ho Song, Chel Hun Choi, et al. · Cancer Research · 90
Increased toll‐like receptor 9 expression in cervical neoplasia
2007 · Jeong‐Won Lee, Jung‐Joo Choi, et al. · Molecular Carcinogenesis · 89
Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)
2019 · E Sun Paik, Myong Cheol Lim, et al. · Gynecologic Oncology · 84
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
2012 · Ha-Jeong Kim, Hye-Kyung Jeon, et al. · European Journal of Cancer · 84
PDF
Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
2018 · Aram Ko, Su Yeon Han, et al. · Cell Death and Differentiation · 83
PDF
Meta-analysis of the effects of beta blocker on survival time in cancer patients
2014 · Chel Hun Choi, Taejong Song, et al. · Journal of Cancer Research and Clinical Oncology · 83
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
2007 · W.Y. KIM, J.-W. LEE, et al. · International Journal of Gynecological Cancer · 80
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results
2009 · Yoo-Young Lee, Chel Hun Choi, et al. · Gynecologic Oncology · 78
Genetic profiling to predict recurrence of early cervical cancer
2013 · Yoo-Young Lee, Tae-Joong Kim, et al. · Gynecologic Oncology · 77
A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications
2016 · Candice Perry, Joon-Yong Chung, et al. · Journal of Histochemistry & Cytochemistry · 76
Works count: 640
Citation count: 11,020
H-index: 51
I10-index: 216
Year
Topic
Type